A 501(c)(3) Organization
Improving access to patient care, research and education related to retina and macular disease.
The cost of medical care continues to rise and access to care, for some patients, is on the decline. While there are county systems available, they are backed up and prompt care is not always possible. They too have limited access to care. Our goal is to open access to the best possible care for those patients who cannot afford it.
While much research has become privatized, it is focused on select drugs or conditions that will make a profit. Our goal is to support the publication of clinical research that may improve patient care but may not generate a profit.
We want to educate the community of patients and providers about the signs, symptoms and tests that may facilitate early detection and treatment of otherwise blinding disease. This agenda includes improving access to diagnostic testing for and treatment of conditions that may lead to blindness.
Thank you to our sponsors who are dedicated to supporting our causes. If you or your company are interested in becoming a sponsor please submit the contact form below.
A physician formulated AREDS II supplement and Multivitamin created to help reduce the risk and stop the progression of macular degeneration.
Eyevance Pharmaceuticals develops innovative and impactful ophthalmic therapies for the ocular surface and anterior segment.
ITEMIZED IN-GOING AND OUTGOING DONATIONS
Where is the money going? Transparency is important to Preserve Vision and Hope, Inc. On our website you can find an itemized list of the donations and how the funding has been used. Anonymous donations are also accepted. This is a 501c non-profit organization.